US drug firm Mylan to buy Indian firm for $1.6 bn
US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.
Feb 27, 2013
0
0